ON DEMAND: ASCO GU 2022 – Highlights through an Australian lens

GU cancer

1 Sep 2022

Watch again as an expert panel present their highlights from the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium and discuss the impacts for patient care in Australia.

Hosted by Conjoint Associate Professor Craig Gedye

Senior Staff Specialist, Calvary Mater Newcastle, NSW; Associate Director, HMRI Clinical Trials Unit; Chair of the Renal Cancer Subcommittee, ANZUP Cancer Trials Group.


Dr Diana Adams. Consultant Medical Oncologist, MacArthur Cancer Therapy Centre, Campbelltown Hospital, NSW.

A/Prof Andrew Weickhardt. Medical Oncologist, General Physician, Olivia Newton-John Cancer and Wellness Centre; Austin Health; Translational Research Fellow, Olivia Newton-John Cancer Research Institute, VIC.

A/Prof Amy Hayden. Radiation Oncologist, Westmead/Blacktown Hospitals & GenesisCare, NSW; Past Chair of the Australian and New Zealand Radiation Uro-Oncology Group (FROGG).

Dr Matthew Roberts. Consultant Urologist, Royal Brisbane and Women’s Hospital and Redcliffe Hospital; Clinician Research Fellow, Metro North Hospital and Health Service; Group Leader, The University of Queensland Centre for Clinical Research, QLD.

Thankyou to our sponsors for providing the non restrictive educational grants that made this program possible.

This event was created independently by the limbic in collaboration with ANZUP, the host and presenters. All studies were selected by the presenters, and all views expressed were those of the host and presenters only. 

Already a member?

Login to keep reading.

Email me a login link